These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 33401106)

  • 21. The Pandemic`s Unresolved Infectious Psycho-Neuro-Immunologies: Myeloid Cells, Vessels, Nasal Cross-Roads.
    Treviranus GRS
    Psychiatr Danub; 2021 Sep; 33(Suppl 9):88-101. PubMed ID: 34559786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myalgic encephalomyelitis/chronic fatigue syndrome post coronavirus disease 2019.
    Kusama Y; Fukui S; Maruyama M; Kamimura K; Maihara T
    Pediatr Int; 2022 Jan; 64(1):e14976. PubMed ID: 35143110
    [No Abstract]   [Full Text] [Related]  

  • 23. Glymphatic System: Emerging Therapeutic Target for Neurological Diseases.
    Xuan X; Zhou G; Chen C; Shao A; Zhou Y; Li X; Zhou J
    Oxid Med Cell Longev; 2022; 2022():6189170. PubMed ID: 35726332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A role for viruses.
    Nunes JM; Kell DB; Pretorius E
    Blood Rev; 2023 Jul; 60():101075. PubMed ID: 36963989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS).
    Preßler H; Machule ML; Ufer F; Bünger I; Li LY; Buchholz E; Werner C; Beraha E; Wagner F; Metz M; Burock S; Bruckert L; Franke C; Wilck N; Krüger A; Reshetnik A; Eckardt KU; Endres M; Prüss H
    Trials; 2024 Mar; 25(1):172. PubMed ID: 38454468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained glymphatic transport and impaired drainage to the nasal cavity observed in multiciliated cell ciliopathies with hydrocephalus.
    Xue Y; Gursky Z; Monte B; Koundal S; Liu X; Lee H; Michurina TV; Mellanson KA; Zhao L; Nemajerova A; Kahle KT; Takemaru KI; Enikolopov G; Peunova NI; Benveniste H
    Fluids Barriers CNS; 2022 Mar; 19(1):20. PubMed ID: 35248089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The glymphatic system and its role in cerebral homeostasis.
    Benveniste H; Elkin R; Heerdt PM; Koundal S; Xue Y; Lee H; Wardlaw J; Tannenbaum A
    J Appl Physiol (1985); 2020 Dec; 129(6):1330-1340. PubMed ID: 33002383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a Better Understanding of the Complexities of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID.
    Tate WP; Walker MOM; Peppercorn K; Blair ALH; Edgar CD
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.
    Apostolou E; Rizwan M; Moustardas P; Sjögren P; Bertilson BC; Bragée B; Polo O; Rosén A
    Front Immunol; 2022; 13():949787. PubMed ID: 36341457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Glymphatic Pathway: Waste Removal from the CNS via Cerebrospinal Fluid Transport.
    Benveniste H; Lee H; Volkow ND
    Neuroscientist; 2017 Oct; 23(5):454-465. PubMed ID: 28466758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity.
    Kedor C; Freitag H; Meyer-Arndt L; Wittke K; Hanitsch LG; Zoller T; Steinbeis F; Haffke M; Rudolf G; Heidecker B; Bobbert T; Spranger J; Volk HD; Skurk C; Konietschke F; Paul F; Behrends U; Bellmann-Strobl J; Scheibenbogen C
    Nat Commun; 2022 Aug; 13(1):5104. PubMed ID: 36042189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Grach SL; Seltzer J; Chon TY; Ganesh R
    Mayo Clin Proc; 2023 Oct; 98(10):1544-1551. PubMed ID: 37793728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The glymphatic pathway in neurological disorders.
    Rasmussen MK; Mestre H; Nedergaard M
    Lancet Neurol; 2018 Nov; 17(11):1016-1024. PubMed ID: 30353860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of increased intracranial pressure on cerebrospinal fluid influx, cerebral vascular hemodynamic indexes, and cerebrospinal fluid lymphatic efflux.
    Xiang T; Feng D; Zhang X; Chen Y; Wang H; Liu X; Gong Z; Yuan J; Liu M; Sha Z; Lv C; Jiang W; Nie M; Fan Y; Wu D; Dong S; Feng J; Ponomarev ED; Zhang J; Jiang R
    J Cereb Blood Flow Metab; 2022 Dec; 42(12):2287-2302. PubMed ID: 35962479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiology of Glymphatic Solute Transport and Waste Clearance from the Brain.
    Zhao L; Tannenbaum A; Bakker ENTP; Benveniste H
    Physiology (Bethesda); 2022 Nov; 37(6):0. PubMed ID: 35881783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post COVID fatigue: Can we really ignore it?
    Sharma P; Bharti S; Garg I
    Indian J Tuberc; 2022 Apr; 69(2):238-241. PubMed ID: 35379408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Lesslar OL; Deed G; Marshall-Gradisnik S
    Mol Med; 2022 Aug; 28(1):98. PubMed ID: 35986236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study.
    Retornaz F; Rebaudet S; Stavris C; Jammes Y
    J Transl Med; 2022 Sep; 20(1):429. PubMed ID: 36153556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The glymphatic system and meningeal lymphatics of the brain: new understanding of brain clearance.
    Yankova G; Bogomyakova O; Tulupov A
    Rev Neurosci; 2021 Nov; 32(7):693-705. PubMed ID: 33618444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible Application of Melatonin in Long COVID.
    Cardinali DP; Brown GM; Pandi-Perumal SR
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.